Evidence map›Paper›PMID 36203129›Full record

ArticleBMC geriatrics2022

Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States.

Joan Forns, Heather E Danysh, Lisa J McQuay, Mary Ellen Turner, Colleen Dempsey, Mary S Anthony, George Demos, J Bradley Layton

Open access · goldAbstract read
In one paragraph

Article in BMC geriatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Joan FornsPharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain. jforns@rti.org.
Heather E DanyshPharmacoepidemiology and Risk Management, RTI Health Solutions, Waltham, MA, USA.
Lisa J McQuayPharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
Mary Ellen TurnerDrug Safety and Pharmacovigilance, ACADIA Pharmaceuticals Inc, Princeton, NJ, USA.
Colleen DempseyDrug Safety and Pharmacovigilance, ACADIA Pharmaceuticals Inc, Princeton, NJ, USA.
Mary S AnthonyPharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
George DemosDrug Safety and Pharmacovigilance, ACADIA Pharmaceuticals Inc, San Diego, CA, USA.
J Bradley LaytonPharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
RTI Health Solutions · USAcadia Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about the incidence of clinical events and treatment patterns among older adults with dementia-related psychosis. Given that dementia-related psychosis comprises various dementia types, this study describes the incidence of clinical events and treatment patterns by dementia type after patients with dementia are diagnosed with psychosis.

methodsAdults aged ≥ 65 years with dementia and newly diagnosed with psychosis were identified in US Medicare claims during 2013-2018. Baseline characteristics were evaluated at the time of the psychosis diagnosis. After the initial psychosis diagnosis, incidence rates (IRs) of clinical events (e.g., falls/fractures, infections, healthcare utilization), mortality, and patterns of antipsychotic treatment were described for each dementia type (Alzheimer's disease [AD], Parkinson's disease dementia [PDD], dementia with Lewy bodies [DLB], frontotemporal dementia [FTD], vascular dementia [VD], and unspecified dementia). Daily mean cumulative counts were estimated to describe the incidence of recurrent events over time. Mortality was described using Kaplan-Meier survival curves.

resultsWe identified 484,520 patients with dementia-related psychosis: mean age, 84 years (standard deviation, 7.8); female, 66%. At the time of psychosis diagnosis, the most prevalent type of dementia was unspecified dementia (56%), followed by AD (31%), VD (12%), PDD (10%), DLB (3%), and FTD (< 1%), and most patients had scores indicating severe illness on the Charlson Comorbidity Index (71%) and frailty index (62%). Across all dementia types, IRs (per 100 person-years) were high for emergency department visits, oral anti-infective use, and urinary tract infections after the initial psychosis diagnosis. Patients with DLB had the highest incidence of most clinical outcomes. After 1 year of follow-up, the cumulative probability of death was about 30% for all dementia types, and after 5 years, was about 80% among patients with DLB, VD, AD, or PDD and about 60%-65% among patients with FTD or unspecified dementia.

conclusionsPatients with dementia-related psychosis had a high burden of comorbidities, frailty, emergency department visits, infections, and death. Specifically, after DRP diagnosis, patients with DLB and VD had the highest burden of clinical events of interest.

Indexed as

Alzheimer DiseaseAntipsychotic AgentsFrailtyFrontotemporal DementiaLewy Body DiseaseParkinson DiseasePsychotic DisordersAgedAged, 80 and overFemaleHumansMaleMedicareUnited StatesAntipsychotic AgentsAlzheimer’s diseaseAntipsychoticsDementia with Lewy bodiesFrontotemporal dementiaHealthcare utilizationInfectionsMedicareMortalityParkinson’s disease dementiaVascular dementia

Identifiers

PMID36203129
PMCPMC9541053
OpenAlexW4302424658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.